About
WhiteSwell is a medical technology company dedicated to improving the treatment of acute decompensated heart failure (ADHF). The company focuses on a minimally invasive catheter-based approach that utilizes the body's lymphatic system to manage fluid overload, which is a common issue in ADHF patients. Their flagship product, the eLym™ System, is designed to enhance lymphatic drainage through a unique impeller pump and restrictors. This system aims to remove excess fluid more effectively than traditional diuretic treatments. The eLym System has received FDA Breakthrough Device Designation, highlighting its innovative approach to heart failure treatment. WhiteSwell holds a strong intellectual property portfolio with over 40 patents related to its catheter technology. The company is supported by clinical data from its ongoing DELTA-HF trial, which shows promising results in decongestion and reduced rehospitalization rates. WhiteSwell targets hospitals, cardiology clinics, and healthcare providers focused on advanced heart failure management solutions.
Technologies
Keywords
Company Information
-
Employees 38
-
Founded 2014
-
Total Funding $30000000
Location
Galway Technology Park, County Galway, Ireland
